Formula Growth’s Pulse Biosciences PLSE Stock Holding History

Formula Growth’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$832K	Hold	30,000	–	–	0.29%	112
2026 Q1	$648K	Buy	+30,000	New	+$554K	0.29%	107

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Formula Growth's PLSE Position: Q2 2026 in Review

Formula Growth held its Pulse Biosciences (PLSE) position steady in Q2 2026 at 30,000 shares worth $832K. The position accounts for 0.29% of the portfolio, ranked #112.

Formula Growth first reported a position in PLSE in Q1 2026 and has held it in 2 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

Formula Growth held 30,000 shares of Pulse Biosciences worth $832K as of Q2 2026.
Formula Growth left its Pulse Biosciences share count unchanged in Q2 2026.
Pulse Biosciences made up 0.29% of Formula Growth's portfolio in Q2 2026, its #112 holding.
Formula Growth first reported a position in Pulse Biosciences in Q1 2026 and has held it in 2 quarters since.
106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.